Lyndra Therapeutics

0 followers


Lyndra Therapeutics is pioneering the first-ever oral, ultra-long-acting, sustained-release therapies, which have the potential to fundamentally change the way people take medicine by enabling patients to take a pill once a week rather than daily.

Industries

Employees

51-200

Links


Org chart

Colin Gardner
Co-Founder
Patrick Boen
Vice President Clinical Development
Anna Legedza
Director, Biostatistics
Maureen Chlopik
Vice President
Michelle O'Connor
Associate Director, Analytical Research And Development
Roman Lovell
Engineer I
Jonathan Raber
Manufacture Engineer
Carmi Mandelkern
Manager, Intellectual Property And Portfolio
Divya Krishnamurthy, Ph.D.
Senior Director, Workplace Operations And Safety

Board & advisors

Amy Schulman
Executive Chair, Co-Founder
Zafrira Avnur
Board Member
Robert Langer
Co-Founder & Board Member
Giovanni Traverso
Co-Founder & Board Member
Douglas Dachille
Board Member
Jillian Moo-Young
Board Member
Kevin G. Guise
Board Member